EU Registry

Clinical Outcomes of Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery With VEST Supported Venous Grafts

Study design & primary objectives

NCT04761068 (clinicaltrials.gov reference #)

Registry period: Q4/2018 – Q1/2021

Sample size: N=550

Participating centers:

13 Centers in Europe:

  1. CardioCentro, Lugano
  2. Triemli, Zurich
  3. AKH, Vienna
  4. Hietzing, Vienna
  5. Medical University Innsbruck
  6. Mauriziano Hospital, Turin 
  7. European Hospital, Rome
  8. Barmherzigen Brüder, Trier
  9. Klinikum Nuernberg
  10. Herzzentrum Dresden* 
  11. Germans Trias i Pujol hospital, Badalona
  12. Ribera Hospital, Valencia
  13. Vila Nova De Gaia, Porto
  14. Terni, 
  15. HUC, Canary Islands


Principal investigator:

Dr. Stefanos Demertzis, Cardiocentro Ticino, Lugano, Switzerland.

Design:
Investigator initiated product registry study.
A prospective, multi-center, open label, post-market all-comers registry.

Primary Objective:
The primary objective is to evaluate the clinical outcomes of CABG surgery with VEST supported SVGs in a large patient population under standard clinical care.

Evaluation will include MACCE, survival, and QoL questionnaire

Current status

Patient enrollment ended Q1 2021, and patients will be followed for 5 years post-index CABG procedure.